Inflammation: A hidden path to breaking the spell of ovarian cancer

Cell Cycle

Volumn 8, Issue 19, 2009, Pages 3107-3111

  Shan, Weiwei ^a   Liu, Jinsong ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cellular senescence; Epithelial ovarian cancer; Fallopian tube; Inflammation; Tumor microenvironment

Indexed keywords

ANDROGEN; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; ESTROGEN; GONADOTROPIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGESTERONE; RANTES; SOMATOMEDIN BINDING PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

CANCER GROWTH; CARCINOGENESIS; CELL AGING; CELL COMMUNICATION; EPITHELIAL OVARIAN CANCER; EPITHELIUM CELL; HUMAN; HYSTERECTOMY; INFLAMMATION; NONHUMAN; OVARY CANCER; OVARY FUNCTION; OVULATION; REVIEW; UTERINE TUBE; UTERINE TUBE LIGATION;

EID: 70349925607     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.19.9590     Document Type: Review

References (44)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10-30.
2. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8-29.
3. Naora H, Montell DJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 2005; 5:355-366 (Pubitemid 40637827)
4. Fathalla MF. Incessant ovulation - a factor in ovarian neoplasia? Lancet 1971; 2:163.
5. Cramer DW, Welch WR. Determinants of ovarian cancer risk II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983; 71:717-721 (Pubitemid 14232385)
6. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998; 90:1774-1786
7. Bonello N, McKie K, Jasper M, Andrew L, Ross N, Braybon E, et al. Inhibition of nitric oxide: effects on interleukin-1beta-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat. Biol Reprod 1996; 54:436-445 (Pubitemid 26031414)
8. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999; 91:1459-1467 (Pubitemid 29424550)
9. Murdoch WJ. Ovarian surface epithelium during ovulatory and anovulatory ovine estrous cycles. Anat Rec 1994; 240:322-326
10. Murdoch WJ. Programmed cell death in preovulatory ovine follicles. Biol Reprod 1995; 53:8-12.
11. Murdoch WJ. Ovarian surface epithelium, ovulation and carcinogenesis. Biol Rev Camb Philos Soc 1996; 71:529-543
12. Espey L. Ovulation as an inflammatory process. In: Sjoberg N, Hamberger L, Janson PO, Owman CH, Coelingh-Bennink HJT, ed. Local Regulation of Ovarian Function. Park Ridge: Parthenon Publishing Group 1992; 183-200.
13. Espey L, Lipner H. Ovulation. In: Knobil E, Neill JD, ed. The Physiology of Reproduction. New York: Raven Press 1994.
14. Freedman RS, Deavers M, Liu J, Wang E. Peritoneal inflammation - A microenvironment for epithelial ovarian cancer (EOC). J Transl Med 2004; 2:23. (Pubitemid 39130349)
15. Crowley-Nowick P. Basic principles of immunology and genital tract immunity. In: Ness R, Kuller LH, ed. Health and disease among women. Biological and environmental influences. New York: Oxford University Press 1998; 273-296
16. Manzi S, Ramsey-Goldman R. Autoimmune diseases. In: Ness R, Kuller LH, ed. Health and disease among women. Biological and environmental influcences. New York: Oxford University Press 1998; 342-372
17. Orvieto R, Fisch N, Yulzari-Roll V, La Marca A. Ovarian androgens but not estrogens correlate with the degree of systemic inflammation observed during controlled ovarian hyperstimulation. Gynecol Endocrinol 2005; 21:170-173 (Pubitemid 41597559)
18. Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 2007; 5:35-44. (Pubitemid 350218778)
19. Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006; 30:230-236 (Pubitemid 43740193)
20. Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 2007; 25:3985-3990 (Pubitemid 47477278)
21. Demopoulos RI, Aronov R, Mesia A. Clues to the pathogenesis of fallopian tube carcinoma: a morphological and immunohistochemical case control study. Int J Gynecol Pathol 2001; 20:128-132 (Pubitemid 32239203)
22. Maisey K, Nardocci G, Imarai M, Cardenas H, Rios M, Croxatto HB, et al. Expression of proinflammatory cytokines and receptors by human fallopian tubes in organ culture following challenge with Neisseria gonorrhoeae. Infect Immun 2003; 71:527-532 (Pubitemid 36026059)
23. McGee ZA, Jensen RL, Clemens CM, Taylor-Robinson D, Johnson AP, Gregg CR. Gonococcal infection of human fallopian tube mucosa in organ culture: relationship of mucosal tissue TNFalpha concentration to sloughing of ciliated cells. Sex Transm Dis 1999; 26:160-165 (Pubitemid 29122740)
24. Strandell A, Thorburn J, Wallin A. The presence of cytokines and growth factors in hydrosalpingeal fluid. J Assist Reprod Genet 2004; 21:241-247 (Pubitemid 39237799)
25. Carvalho JP, Carvalho FM. Is Chlamydia-infected tubal fimbria the origin of ovarian cancer? Med Hypotheses 2008; 71:690-693
26. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370:890-907.
27. Nunobe S, Nakanishi Y, Taniguchi H, Sasako M, Sano T, Kato H, et al. Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia. Pathol Int 2007; 57:315-321 (Pubitemid 46849030)
28. Heller DS, Gordon RE, Katz N. Correlation of asbestos fiber burdens in fallopian tubes and ovarian tissue. Am J Obstet Gynecol 1999; 181:346-347 (Pubitemid 29409911)
29. Cooper MD, Rapp J, Jeffery-Wiseman C, Barnes RC, Stephens DS. Chlamydia trachomatis infection of human fallopian tube organ cultures. J Gen Microbiol 1990; 136:1109-1115
30. Seidman JD, Sherman ME, Bell KA, Katabuchi H, O'Leary TJ, Kurman RJ. Salpingitis, salpingoliths and serous tumors of the ovaries: is there a connection? Int J Gynecol Pathol 2002; 21:101-107
31. Green A, Purdie D, Bain C, Siskind V, Russell P, Quinn M, et al. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer 1997; 71:948-951
32. Ness RB, Grisso JA, Cottreau C, Klapper J, Vergona R, Wheeler JE, et al. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 2000; 11:111-117 (Pubitemid 30112009)
33. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585-621.
34. Parrinello S, Coppe JP, Krtolica A, Campisi J. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 2005; 118:485-496 (Pubitemid 40310116)
35. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-740
36. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001; 98:12072-12077 (Pubitemid 32959828)
37. Shan W, Yang G, Liu J. The inflammatory network: bridging senescent stroma and epithelial tumorigenesis. Front Biosci 2009; 14:4044-4057
38. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6:2853-2868
39. Yang G, Rosen DG, Zhang Z, Bast RC Jr, Mills GB, Colacino JA, et al. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci USA 2006; 103:16472-16477 (Pubitemid 44715220)
40. Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A, et al. A genetically defined model for human ovarian cancer. Cancer Res 2004; 64:1655-1663 (Pubitemid 38428686)
41. Coppe JP, Kauser K, Campisi J, Beausejour CM. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem 2006; 281:29568-29574 (Pubitemid 44536964)
42. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008; 133:1006-1018 (Pubitemid 351795610)
43. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133:1019-1031 (Pubitemid 351787746)
44. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008; 132:363-374 (Pubitemid 351191995)